Delivery Order SPE2DB20D1100-SPE2DB24FC9V8
Award Date
7/29/24
Potential Completion Date
8/19/24
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $7,030.77 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 10, 2024, with a completion date of January 2, 2025. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,265.29 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 6, 2024. The contract has an ultimate completion date of September 27, 2024 and does not utilize a set-aside. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the U.S. Defense Logistics Agency (DLA). The $4,530.60 fixed-price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 8, 2024. The contract has an ultimate completion date of July 29, 2024 and was not set aside for a specific business type. Amerisourcebergen holds a single-award Indefinite Delivery...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The contract, valued at $2,343.59, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order with a performance period through June 12, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, issued by the Defense Logistics Agency (DLA), provides for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The $4,530.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 4, 2024. The award has an ultimate completion date of June 26, 2024 and is not associated with any set-aside requirements. This delivery order is part of AmerisourceBergen's broader...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The award was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a ceiling value of $4,530.60 and a performance period through May 2, 2024. This award is associated with a...
The federal contract award summarized is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024 with a ceiling value of $2,343.59. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 10, 2025. There was no set-aside designation for this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $9,061.20 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The contract has a September 25, 2024 completion date. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of medical...
This federal contract award is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024, with a ceiling value of $7,030.77 and a completion date of December 30, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The $4,530.60 firm-fixed-price delivery order contract has a completion date of November 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a wide range of medical products,...